Stroke Patients Improve with Stem Cells

Long-term stroke patients involved in a small-scale clinical trial of a neural stem-cell therapy show signs of recovery.

By | May 28, 2013

A colony of human embryonic stem cells (middle)WIKIMEDIA, RYDDRAGYNIt was thought that stroke victims couldn’t make any sort of recovery more than 6 months after the stroke. But now, five out of nine long-term stroke patients who took part in a Phase 1 clinical trial of a new therapy in which neural stem cells are injected into the damaged parts of the brain have experienced mild to moderate improvements, reported BBC News.

For example, some participants have recovered the ability to move their fingers and grip objects after several years of complete paralysis, while others are now able to walk around their houses without assistance for the first time in years.

“We are seeing things that are interesting and somewhat surprising,” Hugh Muir, a neuroscientist at the University of Glasgow who is leading the work, told the BBC. “My expectation had been that we would see very little change and if we did see change it would be a relatively short-lived temporary change,” added Muir. “[But] we have seen changes that have been maintained over time.”

The treatment was developed by the company ReNeuron, which first created the stem cells 10 years ago from a sample of nerve tissue taken from a fetus. The promising preliminary results of the trial, taking place at the Southern General Hospital in Glasgow, U.K., will be presented today (May 28) at the European Stroke Conference in London, and the researchers are planning a Phase 2 study, which they hope will give a better idea of whether treatment is the cause of the observed improvements, or if there is some other mechanism at play.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Can Plants Learn to Associate Stimuli with Reward?
  4. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

Business Birmingham